Tamilnad Mercantile Bank Ltd, Marico Ltd, Rossari Biotech Ltd and Nestle India Ltd are among the other gainers in the BSE’s ‘A’ group today, 05 August 2024.

Glenmark Life Sciences Ltd leads gainers in ‘A’ group

The brokerage keeps its EPS estimates unchanged, but increase target price to Rs 885, maintains Add.

Rossari Biotech Q1 Results Review - Steady Performance: ICICI Securities

Rossari Biotech Ltd., incorporated in the year 2009, is a Small Cap company (having a market cap of Rs 4501.56 Crore) operating in Chemicals sector.

Add Rossari Biotech, target price Rs 885: ICICI Securities

Earnings

Rossari Biotech consolidated net profit rises 19.44% in the June 2024 quarter

“Rossari Bio has recently experienced a robust breakout from both its support area and the Fibonacci golden zone at 710, accompanied by notable volume demand. Traders can buy for a target of Rs 840-845 in the next 3-4 weeks,” Jay Patel, Research Head at Investmentor Securities Limited, said.


► Subscribe to The Economic Times for the latest video updates. It's free! - https://www.youtube.com/TheEconomicTimes?sub_confirmation=1

► More Videos @ ETTV - https://economictimes.indiatimes.com/TV

► https://EconomicTimes.com

► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp

Follow ET on:

► Facebook - https://www.facebook.com/EconomicTimes 
► Twitter - https://www.twitter.com/economictimes
► LinkedIn - https://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes

#news #latestnews #economictimes #ET #TheEconomicTimes #businessnews

Stock Radar I Rossari Biotech recently experienced a robust breakout from Fibonacci golden zone

KR Choksey recommended accumulate rating on Rossari Biotech with a target price of Rs 843 in its research report dated October 27, 2023.

Accumulate Rossari Biotech; target of Rs 843: KR Choksey

Rossari Biotech’s reported operating profits at Rs 636 million (+12% YoY; +10% QoQ).

Rossari Biotech Q2 Results Review - Weak Raw Material Prices Led To Tepid Earnings Growth: Yes Securities

Stocks to watch: Shares of firms like ICICI Bank, Paytm, Rossari Biotech, LIC, Hudco, JSW Steel, and others will be in focus on Monday’s trade.

Stocks to Watch: ICICI Bank, Paytm, Rossari Biotech, LIC, Hudco, JSW Steel, and Others - News18

ICICI Securities recommended Reduce rating on Rossari Biotech with a target price of Rs 725 in its research report dated August 01, 2023.

Reduce Rossari Biotech; target of Rs 725: ICICI Securities

KR Choksey is bullish on Rossari Biotech has recommended buy rating on the stock with a target price of Rs 982 in its research report dated August 01, 2023.

Buy Rossari Biotech; target of Rs 982: KR Choksey

The 30-share BSE Sensex climbed 317 points or 0.51 per cent to trade at 62,864, while the broader NSE Nifty moved 83 points or 0.45 per cent higher to trade at 18,617. Mid- and small-cap shares were positive as Nifty Midcap 100 gained 0.32 per cent and the small-cap 100 was up 0.44 per cent.

Sensex rises over 300 points, Nifty trades above 18,600; Rossari Biotech & Tata Chemicals jump up to 7%

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Rossari Biotech is engaged in business of textile and specialty chemical manufacturing.